In a two-part series, as health reform brings a focus on the budget for Medicare, we look from two sides at a little known but influential group convened by the American Medical Association. It's called the Relative Value Scale Update Committee and some critics say it has too much control over the flow of taxpayer dollars in the Medicare program. Tom Scully, senior counsel in Alston & Bird, LLP, in Washington, DC, and former head of the Centers for Medicare & Medicaid Services, tells host Bruce Japsen about problems with the AMA's role in the so-called RUC. In an upcoming program, Bruce Japsen talks with Dr. Barbara Levy, chair of the Relative Value Scale Update Committee.
A Look at an AMA Committee's Clout in Setting Medicare Prices

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
In a two-part series, as health reform brings a focus on the budget for Medicare, we look from two sides at a little known but influential group convened by the American Medical Association. It's called the Relative Value Scale Update Committee and some critics say it has too much control over the flow of taxpayer dollars in the Medicare program. Tom Scully, senior counsel in Alston & Bird, LLP, in Washington, DC, and former head of the Centers for Medicare & Medicaid Services, tells host Bruce Japsen about problems with the AMA's role in the so-called RUC. In an upcoming program, Bruce Japsen talks with Dr. Barbara Levy, chair of the Relative Value Scale Update Committee.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
HF Management for Patients with Comorbid Conditions
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?